Search
Patexia Community
News and Analysis

Our Members

All »
Jessie S
Ardeshir Zia
valter vigolo
Thomas James
Steven Fang
Karen Fernley
sepideh espiary
mike williams
vijay krishna
michelle cipolla
jaya singh
rouz tabaddor
Pedram Sameni
j g shah shah
Mark Pidkowich

Innovation, Technology, and IP News

FDA Approves Qalsody™ for Treatment of ALS

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the...

Brain Computer Interface Developer Announces $33M Series A, Granted FDA “Breakthrough” Designation

Written by:Tom Cowan Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a...

If a Case Was Baseless, It Would Have Ended Sooner

Written by: Matthew Pham & Daniel P. Hughes OneSubsea IP UK Limited v. FMC Technologies, Inc. Before Clevenger, Moore, and Dyk.  Appeal from the United States District...

Low-Bar for Corroboration

Written by: Matthew Friedrichs & Daniel P. Hughes MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. Before Moore, Lourie, and Dyk. Appeal from the Patent Trial and Appeal...

Trademark Monitoring and Enforcement in the Digital Era: Tools and Techniques

In today's digital landscape, protecting your trademarks has become more challenging than ever before. With the rise of e-commerce platforms, social media, and online marketplaces, ...

Feed tagged as "pharmaceuticals":
The Oncomouse Patent: A Milestone in Biotechnology Patents
Mikele Bicolli May 17, 2023
The Oncomouse patent stands as a remarkable milestone in the field of biotechnology patents, revolutionizing the way we approach... Read More »
Comment: 0 Favorite (0)
Implications of the Proposed EU Pharmaceutical Law Reform Overhaul
Knobbe Martens May 10, 2023
Written by:Nima Zargari, Ph.D.  & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
Comment: 0 Favorite (0)
Ensuring a Reference Is Analogous Art to a Challenged Patent, Not to Another Reference
Knobbe Martens May 10, 2023
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC. Before Reyna, Mayer, and Cunningham. Appeal from Patent Trial and Appeal... Read More »
Comment: 0 Favorite (0)
Stipulated Dismissal Undercuts Bid for Attorneys’ Fees
Knobbe Martens May 9, 2023
Written by: Jeremy Anapol UNITED CANNABIS CORPORATION V. PURE HEMP COLLECTIVE INC. Before Lourie, Cunningham, and Stark... Read More »
Comment: 0 Favorite (0)
Claimed Ranges Overlapping the Prior Art Can Lead To Short Patent Shelf-Life
Knobbe Martens May 2, 2023
Written by: Matthew S. Whitehead & Douglas B. Wentzel UCB, INC.  v. ACTAVIS LABORATORIES UT, INC. Before Moore, Chen, and... Read More »
Comment: 0 Favorite (0)
Teva v. GSK: The “Skinny” Label Case Pending Before the Supreme Court
Knobbe Martens Apr 10, 2023
Written by: Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme... Read More »
Comment: 0 Favorite (0)
Description Prescription
Knobbe Martens Mar 6, 2023
Written by: Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before... Read More »
Comment: 0 Favorite (0)
Patent Directed to System for Controlling Access to Drugs Is Not Listable in the Orange Book
Knobbe Martens Feb 27, 2023
Written by: Tyler S. Cox & Kendall Loebbaka JAZZ PHARMACEUTICALS, INC. v. AVADEL CNS PHARMACEUTICALS, LLC Before Lourie... Read More »
Comment: 0 Favorite (0)
BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda
Knobbe Martens Jan 23, 2023
Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »
Comment: 0 Favorite (0)
Evidence of Actual Physician Practice is Relevant in Determination of Direct Infringement
Knobbe Martens Dec 27, 2022
Written by: Kendall Loebbaka & Cesar A. Estrada GENENTECH, INC. V. SANDOZ INC. Before Newman, Lourie, and Prost. Appeal... Read More »
Comment: 0 Favorite (0)
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
Comment: 0 Favorite (0)
Patexia Insight 155: Top ANDA Attorneys of 2022
Pedram Sameni Oct 20, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »
Comment: 0 Favorite (0)
A Skilled Artisan Cannot “At Once Envisage” Each Member of a Large Class
Knobbe Martens Oct 3, 2022
MYLAN PHARMACEUTICALS INC. v. MERCK SHARP & DOHME CORP. Before Lourie, Reyna and Stoll.  Appeal from the Patent Trial and Appeal... Read More »
Comment: 0 Favorite (0)
Patexia Insight 153: Top ANDA Firms of 2022
Pedram Sameni Sep 29, 2022
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused on... Read More »
Comment: 0 Favorite (0)
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More »
Comment: 0 Favorite (0)
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
Pedram Sameni Sep 15, 2022
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by providing... Read More »
Comment: 0 Favorite (0)
Federal Circuit Upholds Lower Court Decision in Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc.
Knobbe Martens Sep 8, 2022
The Federal Circuit has affirmed that Eagle Pharmaceuticals, Inc. did not infringe Par Pharmaceutical, Inc. patents, easing... Read More »
Comment: 0 Favorite (0)
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Mikele Bicolli Aug 28, 2022
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
Comment: 0 Favorite (0)
An ANDA Specification that Directly Addresses Issues of Infringement Controls the Infringement Inquiry
Knobbe Martens Aug 23, 2022
PAR PHARMACEUTICAL, INC. V. EAGLE PHARMACETICALS, INC. Before Moore, Prost, and Hughes. Appeal from the United States District Court for... Read More »
Comment: 0 Favorite (0)
Patexia Insight 148: ANDA Litigation Grows in the First Half of 2022
Pedram Sameni Aug 18, 2022
This morning we released our third annual ANDA Litigation Intelligence Report. The report covers high-level statistics related to Hatch-Waxman... Read More »
Comment: 0 Favorite (0)
Show more Newsfeed posts
Menu